Ten Biomarkers Oncologists Need to Know for Personalized Cancer Care in 2018

Friday, June 1, 2018-Join us for this dynamic CME/CNE-certified satellite symposium at ASCO 2018! Expert faculty will lead discussions on how to leverage some of the emerging and most clinically important biomarkers to optimize patient care across multiple tumor types, from solid tumors to hematologic malignancies.

Sign up now! Registration is complimentary.

Not an official event of the 2018 ASCO Annual Meeting. Not sponsored, endorsed, or accredited by ASCO or the Conquer Cancer Foundation.

Swissôtel Chicago


Route 11 - Gate 31: East Bldg, Level 2, near Arie Crown Theater Box Office
One-way travel time is approximately 12-15 minutes.

Travel alert: Expect delays and allow extra travel time between 3:00 PM and 7:00 PM due to the Taylor Swift Concert at Soldier Field



6:30 PM - 7:00 PM Dinner and Registration

7:00 PM - 7:05 PM Welcome and Introduction

7:05 PM - 7:55 PM Biomarkers Agnostic to Tumor Histology

  • Panel Discussion 1: Understanding Immune Checkpoint Inhibition and DNA Repair Deficiencies
  • Panel Discussion 2: Biomarkers Agnostic to Tumor Histology: Therapeutically Actionable Targets Affecting Cellular Communication and Tumor Growth

7:55 PM - 8:50 PM Case Studies: Tumor Specific Personalized Care and Implications in the Clinic

  • Panel Discussion 3: New Biomarker Insights to Optimize Treatment Decisions for Patients With Lung Cancer
  • Panel Discussion 4: Key Biomarkers That Guide Therapeutic Decisions for Patients With Hematologic Malignancies

8:50 PM - 9:00 PM Final Thoughts and Summary


Date / Time
Event Details


Program Chair
John L. Marshall, MD

Chief, Division of Hematology/Oncology
Department of Medicine
Georgetown University Hospital
Washington, DC

Todd M. Bauer, MD

Associate Director, Drug Development
Sarah Cannon Research Institute
Tennessee Oncology, PLLC
Nashville, Tennessee

Hagop M. Kantarjian, MD

Department of Leukemia
Professor of Medicine
The University of Texas M.D. Anderson Cancer Center
Houston, Texas

Edward S. Kim, MD, FACP

Andrew D. Zelenetz, MD, PhD

Medical Director, Quality Informatics
Attending Physician, Lymphoma Service
Department of Medicine
Memorial Sloan Kettering Cancer Center
Professor of Medicine
Weill-Cornell Medical College
New York, New York

Goal Statement
The goal of this activity is to improve participants’ competence in applying biomarkers to guide cancer therapy.

Target Audience 
This program is intended for physicians, nurses, and other healthcare providers who care for patients with cancer.

Learning Objectives 

  • Apply predictive biomarkers to guide therapeutic decisions for patients with cancer
  • Evaluate the available data and expert recommendations to determine which biomarkers should be tested in your patients with cancer
  • Explain to patients the need for an additional biopsy to test for appropriate biomarkers in cases where the initial biopsy sample was insufficient or if the biomarker status was previously unknown
  • Identify patients and determine eligibility to enroll on important ongoing clinical trials based on molecular testing of their tumor


Physician Continuing Medical Education

Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC. The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation
The Annenberg Center for Health Sciences at Eisenhower designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest
The Annenberg Center for Health Sciences at Eisenhower requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to the Annenberg Center for Health Sciences at Eisenhower policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.

Nursing Continuing Education

Accreditation Statement
Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Credit Designation
2.0 contact hours may be earned for successful completion of this activity.

Provider approved by the California Board of Registered Nursing, Provider Number 13664, for 2.0 contact hours. A statement of credit will be issued only upon receipt of a completed activity evaluation form and will be emailed to you within 3 weeks.